Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurosci Biobehav Rev. 2004 Oct;28(6):547-63.

Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.

Author information

  • 1Department of Nuclear Medicine, University Hospital, University of Leipzig, Leipzig, Germany. hessw@medizin.uni-leipzig.de

Erratum in

  • Neurosci Biobehav Rev. 2005;29(7):1119.

Abstract

Alterations of central serotonergic neurotransmission, particularly changes in the presynaptically located serotonin transporter (SERT) availability, are thought to be one of the major pathomechanisms of neuropsychiatric symptoms. Modern neuroimaging techniques such as single-photon emission computed tomography and positron emission tomography employ radiolabeled tracers, which bind to SERT, and thus, allow detection of cerebral SERT availability in vivo. We review SERT imaging studies in patients with depression, anxiety disorders, eating disorders and patients with neurological diseases. We furthermore elucidate the potential of SERT imaging techniques in estimating the effect of selective serotonin reuptake-inhibitors.

PMID:
15527862
DOI:
10.1016/j.neubiorev.2004.08.004
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center